RELATIONSHIP BETWEEN ONE-STAGE AND CHROMOGENIC FVIII ASSAY DISCREPANCIES AND GENETIC ANALYSIS OF FVIII GENE IN PATIENTS WITH NON-SEVERE HAEMOPHILIA A

被引：0
|
作者：
Obregon, J. [1 ]
Calvo Villas, J. M. [1 ]
Marco Rico, A. [2 ]
Herrero Martin, S. [3 ]
Urena, L. E. [4 ]
Lopez Jaime, F. J. [5 ]
Diaz Jordan, B. [6 ]
Garcia Diaz, C. [7 ]
Jurado Herrera, S. [8 ]
Perez Gonzalez, N. F. [8 ]
Garcia Candel, F. [9 ]
Marco Vera, P.
Fernandez Bello, I.
Montano Brioso, A. [10 ]
机构：
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
[2] Hosp Gen Univ Alicante Doctor Balmis, Alicante, Spain
[3] Hosp Univ Guadalajara, Guadalajara, Spain
[4] Hosp Univ Virgen Ias Nieves, Granada, Spain
[5] Hosp Univ Reg Malaga, Malaga, Spain
[6] Hosp Gen Valdepenas, Ciudad Real, Spain
[7] Hosp Univ Burgos, Burgos, Spain
[8] Hosp Univ Torrcardenas, Almeria, Spain
[9] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
[10] Univ Salamanca, Hosp Univ Reg Malaga, Malaga, Spain
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO007
引用
收藏
页码：26 / 27
页数：2
相关论文
共 37 条
  • [21] In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies
    Behnaz Pezeshkpoor
    M. Gazorpak
    A-C. Berkemeier
    H. Singer
    A. Pavlova
    A. Biswas
    J. Oldenburg
    Annals of Hematology, 2019, 98 : 1855 - 1865
  • [22] In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies
    Pezeshkpoor, Behnaz
    Gazorpak, M.
    Berkemeier, A-C.
    Singer, H.
    Pavlova, A.
    Biswas, A.
    Oldenburg, J.
    ANNALS OF HEMATOLOGY, 2019, 98 (08) : 1855 - 1865
  • [23] Comparison of the behavior of different factor VIII products measured with the chromogenic Factor VIII activity assay and the FVIII one-stage clotting assay
    Duren, Clintvan
    Polenewen, Robert
    Brons, Paul
    Laros, Britta
    Schutgens, Roger
    Van Heerde, Waander L.
    HAEMOPHILIA, 2014, 20 : 37 - 37
  • [24] A blinded in vitro study with Refacto® mock plasma samples:: similar FVIII results between the chromogenic assay and a one-stage assay when using a higher cephalin dilution
    Caron, C
    Dautzenberg, MD
    Delahousse, B
    Droulle, C
    Pouzol, P
    Dubanchet, A
    Rothschild, C
    HAEMOPHILIA, 2002, 8 (05) : 639 - 643
  • [25] Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B
    Zwagemaker, Anne-Fleur
    Kloosterman, Fabienne R.
    Gouw, Samantha C.
    Boyce, Sara
    Brons, Paul
    Cnossen, Marjon H.
    Collins, Peter W.
    Eikenboom, Jeroen
    Hay, Charles
    Hengeveld, Rutger C. C.
    Jackson, Shannon
    Klopper-Tol, Caroline A. M.
    Kruip, Marieke J. H. A.
    Laros-van Gorkom, Britta
    Male, Christoph
    Nieuwenhuizen, Laurens
    Shapiro, Susan
    Fijnvandraat, Karin
    Copens, Michiel
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (04) : 850 - 861
  • [26] Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype
    Oldenburg, J.
    Pavlova, A.
    HAMOSTASEOLOGIE, 2010, 30 (04): : 207 - 211
  • [27] Discrepancies between the one-stage clotting assay and chromogenic assay in patients with hemophilia A receiving standard or extended half-life factor VIII products in clinical settings
    Nagao, Azusa
    Kaneko, Makoto
    Kazama, Fuminori
    Oda, Nozomi
    Nojima, Masanori
    Suzuki-Inoue, Katsue
    Suzuki, Takashi
    THROMBOSIS RESEARCH, 2020, 185 : 150 - 152
  • [28] Agreement between one stage and chromogenic assays in samples from patients receiving recombinant porcine FVIII (Obizur, Susoctocog-alfa)
    Guy, Susan
    Bowyer, Annette E.
    Shepherd, M. Fiona
    Maclean, Rhona M.
    Kitchen, Steve
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (01) : 135 - 140
  • [29] Molecular genetic background of haemophilia A patients with discrepancy between one-stage and two-stage factor VIII assays
    Pavlova, A.
    Delev, D.
    Pahl, S.
    Driesen, J.
    Brondke, H.
    Oldenburg, J.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S153 - S155
  • [30] Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study
    Hillarp, A.
    Bowyer, A.
    Ezban, M.
    Persson, P.
    Kitchen, S.
    HAEMOPHILIA, 2017, 23 (03) : 458 - 465
1234